The latest news about HotHouse Therapeutics
We are delighted to announce that HotHouse Therapeutics' co-founder, Prof. Anne Osbourn, has been elected to the Medicine and Life Sciences Division of the European Academy of Sciences (EurASc).
Read moreProfessor Anne Osbourn is bringing global attention to the fragile supply of one of the world’s most important vaccine ingredients.
Read moreWe will be at Cambridge Tech Week on Tuesday 16th Sept - please come and find us at the Cambridge Management Consulting stand!
Read moreWe are delighted to be amongst the finalists at the East of England Tech Innovator UK awards.
Read moreLondon Tech Week provides an excellent opportunity to showcase what we are developing at HotHouse Therapeutics to a brilliant tech audience.
Read more